Ikarian Capital »

Spruce Biosciences shares owned by Ikarian Capital

Quarter-by-quarter ownership of Spruce Biosciences shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Spruce Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Spruce Biosciences held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spruce Biosciences by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $119k 13k 8.95

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Spruce Biosciences

Carlyle
Cable Car Capital
Ikarian Capital
Lion Point Capital
Advisor Group Holdings
UBS Group
Caldwell Sutter Capital

View all funds holding Spruce Biosciences